Navigation Links
Mendelsohn elected to American Academy of Arts and Sciences
Date:4/25/2013

HOUSTON John Mendelsohn, M.D., director of The University of Texas MD Anderson Cancer Center's Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy and former president of MD Anderson, has been elected as a fellow of the American Academy of Arts and Sciences.

The 230-year-old academy established to cultivate the arts and sciences and to gather scholars, professionals, government officials and business leaders to work together in the national interest, announced its new fellows today. Only current fellows may nominate others to join the academy.

"I am honored to be joining this collection of thinkers from many walks of life and look forward to collaborating with them to address important public issues," Mendelsohn said.

In addition to its role as a prestigious honorary society, the academy is a leading center for independent policy research. Members contribute to academy publications and studies of science, technology, energy, global security, the humanities, culture and education.

"Election to this prestigious group recognizes John Mendelsohn's achievements as a scientist, physician and leader," said MD Anderson President Ron DePinho, M.D., and an academy fellow. "As a fellow, he will have a vibrant forum to lend his deep insights to policy research and development, to the great benefit of our country and humanity."

Mendelsohn, president of MD Anderson from 1996-2011, also is a member of the Institute of Medicine of the National Academy of Sciences and has participated in or led a variety of studies there, including one proposing reform of cancer clinical trials.

He also is the L.E. and Virginia Simmons Fellow in Health and Technology Policy at Rice University's Baker Institute. His work there focuses on the identification and evaluation of new health technologies, therapeutics and best practices as well as the promotion of policy recommendations to improve national and global health outcomes.

As director of MD Anderson's personalized cancer treatment institute, he leads efforts to tailor cancer treatment to individual patients by analyzing tumor genetics to match an optimal, targeted therapy to their disease.

Mendelsohn is a pioneer in the development of targeted therapy. His research on how the binding of growth factors to receptors on the surface of cells regulates cell functions led to his development of an antibody to block growth signals to the epidermal growth factor receptor. The resultant drug, known as cetuximab or Erbitux, was approved by the U.S. Food and Drug Administration to treat colon and head and neck cancers.

Academy fellows announced Wednesday are an eclectic group, including a variety of scientists and professionals as well as singer Bruce Springsteen, actor Robert DeNiro and novelist Annie Dillard.

Mendelsohn served for 10 years as the founding editor-in-chief of the journal, Clinical Cancer Research, and on numerous editorial boards. He has been honored many times for his contributions to cancer research with major awards, including the Joseph H. Burchenal Clinical Research Award from the American Association for Cancer Research (1999), the David A. Karnofsky Memorial Award from the American Society of Clinical Oncology (2002), the Fulbright Lifetime Achievement Medal (2005), the Dan David Prize in Cancer Therapy (2006), the Dorothy P. Landon AACR Prize for Translational Research (2008), and the Sixth Annual AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research (2012).

New fellows of the American Academy will be inducted at a ceremony Oct. 12 at the academy's headquarters in Cambridge. A list of the honorees for 2013 is posted at https://www.amacad.org/members.aspx.


'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-362-7310
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Related medicine news :

1. Hutchinson Center president elected to American Academy of Art and Sciences
2. UT MD Anderson President Ronald DePinho elected to National Academy of Sciences
3. Cleveland Clinic selected to participate in National MDS Clinical Research Consortium
4. IQware Solutions is Pleased to Announce that IQware MTM has Been Selected by the Tennessee Pharmacists Research and Education Foundation (TPREF)
5. ONR system selected to help DoD track human subjects studies
6. Hospital of the University of Pennsylvania selected to lead US nurse-training initiative
7. Half-match bone marrow transplants wipe out sickle cell disease in selected patients
8. Wolters Kluwer Health selected as publisher for the Harvard Review of Psychiatry
9. Dr. Joan Miller selected to deliver the prestigious Edward Jackson Memorial Lecture
10. Mangos Selected by Liberty Sport as Advertising Agency Partner
11. Richard Mayeux, M.D., M.S., elected Fellow of AAAS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... (PRWEB) , ... ... ... For Immediate ... Polling Shows Young Women Seek Sex and Relationship Advice from ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet today announces the ... healthy lifestyles and highlighting the importance of proactive eye and ear health. The ... the latest innovations in hearing aid technology. , In this issue, the ...
(Date:8/18/2017)... WV (PRWEB) , ... August 18, 2017 , ... ... financial consulting services and asset protection assistance to communities in North-Central West Virginia, ... provide critical services to at-risk boys in the area. , The Chestnut Mountain ...
(Date:8/18/2017)... ... August 18, 2017 , ... Goss & Associates ... residential and commercial clients in the greater Houston region, is helping locally recognized ... the fight against cancer. , Founded by Tony and Amber Bender after losing ...
(Date:8/18/2017)... ... ... Overseer at The House of Yahweh in Abilene, Texas, has released a new publication this ... of the Savior whom the world calls “Mother Mary”. Yisrayl says when compared to what ... historical woman. , “The world bows, kisses the feet of, cries out to and ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Aug. 15, 2017   Mostyn Law and Gulf Coast ... Houston, Texas . The Mostyn Law family has ... years. That is why Mostyn Law is partnering with ... to show its appreciation. Blood supplies are running low. ... short of hospital needs in August. That is why the blood ...
(Date:8/15/2017)... 15, 2017  AOTI Inc. announced today that its fully owned ... recently opened a New York City Office in Yonkers, ... unique Topical Wound Oxygen (TWO 2 ) homecare therapy. This new ... for Health Care (ACHC) under the company,s DMEPOS accreditation for Home/Durable ... Advanced ...
(Date:8/8/2017)... AVIV, Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: ... immunology, today reports its financial results for the second ... achievements during the second quarter 2017 and to date: ... multiple clinical development programs for the Company,s lead project, ... 3 pivotal study with BL-8040 as novel stem cell ...
Breaking Medicine Technology: